Dexcom announced recently that the FDA has cleared its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes ages two years and older. Dexcom says it is working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as...
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society. The guideline, titled “Management of Individuals with Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline,” was published online and will appear in the March 2023 print...
People with Diabetes May Benefit More from a Pancreas Transplant than Other Treatments
Results of pancreas transplantation continue to improve and up to 90% of recipients with diabetes enjoy freedom from both insulin therapy and the need for close glucose monitoring following the procedure, according to a new paper published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Pancreas transplantation is a type of surgery in which a...
- Diabetes News and Research
- ENDO 2022
- Trends and Insights
- Diabetes Research Articles
- Neoplasia and Cancer
- Women's Health
Study Links Diabetes and Worse Outcomes in Long-Term Survivors of Metastatic Breast Cancer
Women who are longer-term survivors of metastatic breast cancer may have a worse survival rate if they have diabetes and poorly controlled blood sugar levels, according to a study presented at ENDO 2022. The authors of the study point out that a well-established relationship between diabetes and breast cancer exists, but it’s still unclear how...
With new technology and new drugs changing diabetes treatment at an unprecedented pace, the Endocrine Society’s “Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Guideline” looks through the latest evidence on glycemic control for the most comprehensive guidance on selecting the optimal approach in hospitalized patients. The practice of...
Last summer, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes and in adults with type 2 diabetes. The FDA granted approval for insulin glargine-yfgn to Mylan Pharmaceuticals Inc., who is marketing the product as Semglee. Semglee...
Black People with Diabetes Disproportionately Affected by Diabetic Ketoacidosis During COVID
Black people with diabetes were more likely to develop cases of a life-threatening complication called diabetic ketoacidosis during the pandemic, even in people without COVID-19, according to a new study from the T1D Exchange published in The Journal of Clinical Endocrinology and Metabolism. People with diabetes are more likely to get extremely sick from COVID-19,...
People with Diabetes Who Eat Less Processed Food at Night May Live Longer
Study finds eating carbs earlier in the day is linked to better heart health. The time of day that people with diabetes eat certain foods may be just as important to their well-being as portion size and calories, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. Mealtimes...
